NASDAQ:CPIX

Cumberland Pharmaceuticals - CPIX Stock Forecast, Price & News

$2.30

+0.02 (+0.88%)

(As of 08/18/2022 04:22 PM ET)

Add

Compare

Today's Range: $2.12
▼
$2.30
50-Day Range: $1.93
▼
$2.56
52-Week Range: $1.89
▼
$7.51

Volume: 12,783 shs
Average Volume: 55,609 shs
Market Capitalization: $33.72 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Cumberland Pharmaceuticals MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.95% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.33
Based on 4 Articles This Week
Insider Trading: Acquiring Shares
$1,155 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars

Medical Sector

969th out of 1,119 stocks

Pharmaceutical Preparations Industry

477th out of 549 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cumberland Pharmaceuticals.

4.0

Short Interest

Percentage of Shares Shorted
0.95% of the float of Cumberland Pharmaceuticals has been sold short.
Short Interest Ratio / Days to Cover
Cumberland Pharmaceuticals has a short interest ratio ("days to cover") of 6.2.
Change versus previous month
Short interest in Cumberland Pharmaceuticals has recently decreased by 21.17%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Cumberland Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Cumberland Pharmaceuticals does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CPIX.

1.9

News and Social Media Coverage

News Sentiment
Cumberland Pharmaceuticals has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Cumberland Pharmaceuticals this week, compared to 9 articles on an average week.
Search Interest
Only 1 people have searched for CPIX on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
3 people have added Cumberland Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cumberland Pharmaceuticals insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,155.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
43.55% of the stock of Cumberland Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 19.11% of the stock of Cumberland Pharmaceuticals is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cumberland Pharmaceuticals is -4.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cumberland Pharmaceuticals is -4.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cumberland Pharmaceuticals has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Cumberland Pharmaceuticals Stock Performance

Shares of CPIX opened at $2.28 on Thursday. Cumberland Pharmaceuticals has a fifty-two week low of $1.89 and a fifty-two week high of $7.51. The company has a current ratio of 1.80, a quick ratio of 1.44 and a debt-to-equity ratio of 0.48. The business's 50-day moving average is $2.19 and its 200-day moving average is $2.53.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Cumberland Pharmaceuticals in a report on Wednesday. They set a "hold" rating on the stock.

Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Stock News Headlines

August 13, 2022 | seekingalpha.com

Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q2 2022 Results - Earnings Call Transcript

August 12, 2022 | msn.com

Cumberland County officials to conduct mosquito control spray

August 10, 2022 | msn.com

Italian restaurant to open in Cumberland County development

August 10, 2022 | americanbankingnews.com

Cumberland Pharmaceuticals (NASDAQ:CPIX) Receives New Coverage from Analysts at StockNews.com

August 10, 2022 | msn.com

Cumberland County man charged with stealing $88,000 from care-dependent family member

August 9, 2022 | msn.com

Death investigations on the rise in Cumberland County

August 9, 2022 | finance.yahoo.com

Cumberland Pharmaceuticals Reports 14% Revenue Growth

August 9, 2022 | msn.com

Two people rescued from Cumberland County wilderness in complex multi-agency effort

August 9, 2022 | msn.com

Here Comes the Bus app allows Cumberland County parents to track school bus location

August 8, 2022 | msn.com

Pair of tubers rescued in Cumberland County wilderness after 911 call

August 8, 2022 | finance.yahoo.com

CUMBERLAND PHARMACEUTICALS REPORTS 2.4M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2021

August 8, 2022 | americanbankingnews.com

Cumberland Pharmaceuticals (CPIX) Scheduled to Post Earnings on Tuesday

August 8, 2022 | msn.com

Cumberland falls short in Metro Regional, losing 3-2 to New Jersey

August 8, 2022 | msn.com

'Fast service, cheap drinks': New Cumberland bar prepares for Tennessee football fans

August 7, 2022 | msn.com

Several injured after fireworks incident in Cumberland

August 7, 2022 | usnews.com

‘Something Beautiful’: Husband, Wife Paint Cumberland Mural

August 6, 2022 | msn.com

1 dead in Cumberland County Motorcycle Crash, I-95 reopened

August 6, 2022 | msn.com

VBSPCA receives 17 beagles from Cumberland breeding facility

August 5, 2022 | msn.com

Pennsylvania State Police led on lengthy chase in Cumberland County

August 4, 2022 | msn.com

Cumberland County manhunt suspects stole State Police vehicle, captured; PSP

August 4, 2022 | msn.com

Suspect taken into custody after manhunt in Cumberland County

August 3, 2022 | msn.com

Cumberland LL preparing for regionals in CT

August 2, 2022 | msn.com

What you need to know about monkeypox as first case is reported in Cumberland County

August 2, 2022 | finance.yahoo.com

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS

August 2, 2022 | msn.com

Cumberland County confirms first case of monkeypox

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Company Calendar

Last Earnings: 8/10/2021
Today: 8/18/2022
Next Earnings (Estimated): 11/08/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Sector: Medical
Current Symbol: NASDAQ:CPIX
CUSIP: 23077010
CIK: 1087294
Web: www.cumberlandpharma.com
Phone: (615) 255-0068
Fax: 615-255-0094
Employees: 83
Year Founded: 1999

Profitability

EPS (Most Recent Fiscal Year): ($0.51)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,510,000.00
Net Margins: -20.13%
Pretax Margin: -22.99%
Return on Equity: -5.90%
Return on Assets: -2.76%

Debt

Debt-to-Equity Ratio: 0.48
Current Ratio: 1.80
Quick Ratio: 1.44

Sales & Book Value

Annual Sales: $35.99 million
Price / Sales: 0.94
Cash Flow: $0.32 per share
Price / Cash Flow: 7.17
Book Value: $2.67 per share
Price / Book: 0.86

Miscellaneous

Outstanding Shares: 14,662,000
Free Float: 8,277,000
Market Cap: $33.72 million
Optionable: Optionable
Beta: 0.34

Social Links

Key Executives

Mr. A. J. Kazimi MBA (Age 64)
Founder, Chairman, Pres & CEO
Comp: $872.63k
Mr. John Michael Hamm (Age 65)
Sr. Director of Fin. & Accounting and CFO
Comp: $304.91k
Mr. James Lowrance Herman (Age 67)
Exec. VP of National Accounts & Chief Compliance Officer
Comp: $320.65k
Ms. Jean W. Marstiller (Age 72)
Sr. VP of Admin. Services & Corp. Sec.
Ms. Cindy B. Patton (Age 69)
Sr. Director of Field Marketing
Mr. Adam S. Mostafa (Age 42)
Managing Director
Mr. Todd M. Anthony
VP of Organizational Devel.
Ms. Erin Smith Gull
Sr. Corp. Relations Associate

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CPIX Stock - Frequently Asked Questions

How have CPIX shares performed in 2022?: Cumberland Pharmaceuticals' stock was trading at $4.67 at the beginning of 2022. Since then, CPIX shares have decreased by 51.2% and is now trading at $2.28.
View the best growth stocks for 2022 here.
When is Cumberland Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our CPIX earnings forecast.
How were Cumberland Pharmaceuticals' earnings last quarter?: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its quarterly earnings results on Tuesday, August, 10th. The specialty pharmaceutical company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.17. The specialty pharmaceutical company earned $9.06 million during the quarter, compared to the consensus estimate of $8.57 million. Cumberland Pharmaceuticals had a negative trailing twelve-month return on equity of 5.90% and a negative net margin of 20.13%.
What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?: 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Cumberland Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), CorMedix (CRMD) and Xeris Biopharma (XERS).

What is Cumberland Pharmaceuticals' stock symbol?: Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."
Who are Cumberland Pharmaceuticals' major shareholders?: Cumberland Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (4.21%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, Gordon R Bernard, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas.
View institutional ownership trends.
How do I buy shares of Cumberland Pharmaceuticals?: Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cumberland Pharmaceuticals' stock price today?: One share of CPIX stock can currently be purchased for approximately $2.28.
How much money does Cumberland Pharmaceuticals make?: Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $33.42 million and generates $35.99 million in revenue each year. The specialty pharmaceutical company earns $-3,510,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.
When was Cumberland Pharmaceuticals founded?: Cumberland Pharmaceuticals was founded in 1999.
How can I contact Cumberland Pharmaceuticals?: Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094.

This page (NASDAQ:CPIX) was last updated on 8/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Cumberland Pharmaceuticals - CPIX Stock Forecast, Price & News

Cumberland Pharmaceuticals MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock

Cumberland Pharmaceuticals Stock Performance

Wall Street Analyst Weigh In

CPIX Stock News Headlines

CPIX Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

CPIX Stock - Frequently Asked Questions

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™